Title : Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.

Pub. Date : 2005 Apr 29

PMID : 15728586






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phenylephrine-induced cardiac hypertrophy in neonatal rat cardiomyocytes caused a reduction in the expression of pyruvate dehydrogenase kinase 4 (Pdk4), a target gene of PPARbeta/delta involved in fatty acid utilization, and a fall in palmitate oxidation that was reversed by NF-kappaB inhibitors. Fatty Acids peroxisome proliferator-activated receptor delta Rattus norvegicus
2 These results indicate that NF-kappaB activation during cardiac hypertrophy down-regulates PPARbeta/delta activity, leading to a fall in fatty acid oxidation, through a mechanism that involves enhanced protein-protein interaction between the p65 subunit of NF-kappaB and PPARbeta/delta. Fatty Acids peroxisome proliferator-activated receptor delta Rattus norvegicus
3 These results indicate that NF-kappaB activation during cardiac hypertrophy down-regulates PPARbeta/delta activity, leading to a fall in fatty acid oxidation, through a mechanism that involves enhanced protein-protein interaction between the p65 subunit of NF-kappaB and PPARbeta/delta. Fatty Acids peroxisome proliferator-activated receptor delta Rattus norvegicus